Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy

NCT04207775 · clinicaltrials.gov ↗
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca